About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, February 15th, 2018

The QualityStocks
Daily Stock List


Sun BioPharma, Inc. (SNBP)

AheadoftheBulls, AllPennyStocks, TheStockWizards.net, The Dean, FeedBlitz, MicrocapVoice, Today's Financial News, HotPennyStocksNow, OTC Picks, Hot Shot Stocks, Wall Street Resources, Beacon Equity Research, Greenbackers, CoolPennyStocks, Otcstockexchange, HotOTC, and Lebed.biz reported previously on Sun BioPharma, Inc. (SNBP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sun BioPharma, Inc. is a biopharmaceutical company listed on the OTC Markets Group’s OTCQB. The Company is developing disruptive therapeutics for the treatment of patients with pancreatic diseases. A clinical-stage biopharmaceutical company, Sun BioPharma’s development programs target diseases of the pancreas. This includes pancreatic cancer and pancreatitis. Sun BioPharma has its corporate headquarters in Waconia, Minnesota.

The Company’s initial product candidate is SBP-101. This product is for the treatment of patients with pancreatic cancer. Mr. Ray Bergeron, Ph.D. Distinguished Professor Emeritus, University of Florida invented SBP-101. Sun BioPharma’s plan is to develop SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma, which is the most common kind of pancreatic cancer.

SBP-101 is a first-in-class, proprietary, polyamine compound. The design of it is to exert therapeutic effects in a mechanism specific to the pancreas. The Company originally licensed SBP-101 from the University of Florida in 2011.

The molecule has been demonstrated to be highly effective in human pancreatic cancer models. It has shown superior activity to existing Food and Drug Administration (FDA) approved chemotherapy agents. Additionally, combination therapy potential has been demonstrated for pancreatic cancer.

In addition, Sun BioPharma’s SBP-102 is presently in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. As well, Sun BioPharma’s SBP-103 is currently in non-clinical exploratory evaluation.

Sun BioPharma has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, California; the University of Miami; the University of Florida; the Mayo Clinic Scottsdale; the Austin Health Cancer Trials Centre and the Box Hill Hospital in Melbourne, Australia, and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma announced in October 2017 the successful completion of patient enrolment in its Phase 1a dose escalation safety study using SBP-101 for patients with previously treated locally advanced or metastatic pancreatic ductal adenocarcinoma (PDA). Upon reviewing data from the sixth and final cohort of patients, and data from all 29 patients enrolled in the study, the Data Safety Monitoring Board (DSMB) recommended a safe and well-tolerated dose level of SBP-101 to be used for more clinical development.

In late January, Sun BioPharma announced its initiation of a first-line dose-escalation study of SBP-101 in combination with gemcitabine and nab-paclitaxel in previously untreated patients with metastatic pancreatic cancer. The anticipation is that the first patient will be enrolled in early Q2 2018.

The expectation is that clinical sites participating in the study will include the University of Florida, in Gainesville, Florida, the Ashford Cancer Centre in Adelaide, the Olivia Newton-John Cancer and Wellness Centre in Melbourne and the Blacktown Cancer and Haematology Centre in Sydney, Australia.

Furthermore, Sun BioPharma announced the completion of the first-in-human safety study of SBP-101 in previously treated patients with pancreatic ductal adenocarcinoma (PDA). SBP-101 was well tolerated. Moreover, signals of efficacy were observed at dose levels below the Maximum Tolerated Dose (MTD).

Sun BioPharma, Inc. (SNBP), closed Thursday's trading session at $9.75, up 8.33%, on 622 volume with 7 trades. The average volume for the last 60 days is 427 and the stock's 52-week low/high is $1.00/$45.00.

NextSource Materials, Inc. (NSRCF)

MarketWatch, Investors Hub, and Stockhouse reported on NextSource Materials, Inc. (NSRCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NextSource Materials, Inc. is developing its 100 percent-owned Molo Graphite Project in southern Madagascar. The Company is developing the world’s next source of high quality flake graphite. The Molo Graphite Project is a feasibility-stage project. It ranks as one of the largest-known and highest quality flake graphite deposits internationally. A mine development enterprise, NextSource Materials lists on the OTCQB.

The Molo Graphite Project is 160 kilometers by road southeast of Madagascar’s administrative capital - and port city - of Toliara. It is 220 kilometers from the Port of Ehoala at Fort Dauphin.

The Project hosts a National Instrument 43-101 (NI 43-101) compliant total combined graphite resource of 141.28 million tonnes (Mt) at 6.13 percent total graphitic carbon (C), with a contained ore reserve of 22.44 Mt at 7.02 percent C.

The Molo Graphite Project deposit is 11.5 kilometers east of the town of Fotadrevo in the Tulear area of south-western Madagascar. It encompasses a region of 62.5 hectares within the Company’s overall property claim position of 425km2.

A Feasibility Study (FS) for the Project completed in February of 2015. The Study confirmed that the Molo Graphite Project is expected to be a lowest-quartile producer because of its low-cost, open pit operation that has a negligible stripping ratio. In February of 2017, an updated FS was undertaken to reflect the Company’s phased approach to production, using a “mining first” full-modular mine build philosophy.

Phase 1 will consist of a processing plant. Phase 2 will be the expansion of SuperFlake™ production to 50,000 tonnes annually, as envisioned in NextSource Materials’ 2015 FS. The expectation is that commissioning and production of the Molo Graphite Project will start this year.

NextSource Materials earlier reported the positive results of its updated FS for its 100 percent-owned Molo Graphite Project. The updated FS was undertaken to reflect its decision to revise Phase 1 of its Molo Graphite Project mine plan from a demonstration plant to a fully operational and sustainable graphite mine with a permanent processing plant capable of producing roughly 17,000 tpa of high-quality SuperFlake™ concentrate each year with a mine life of 30 years.

NextSource Materials has successfully registered SuperFlake® as a trademark in Europe. The registration of the SuperFlake® trademark means that NextSource now has the exclusive right to use this trademark on all natural graphite sold in the European Union that it produces from its feasibility-stage Molo Graphite Project in Madagascar.

On December 29, 2017, NextSource Materials announced the completion of the redomicile of the Company from Minnesota into Canada under the Canada Business Corporations Act (CBCA). Effective December 27, 2017, NextSource Materials is now a corporation governed and subject to the CBCA. The Redomicile was earlier approved by stockholders at the most recent annual and special meeting of shareholders held on December 5, 2017. NextSource Materials is headquartered in Toronto, Ontario.

NextSource Materials, Inc. (NSRCF), closed Thursday's trading session at $0.1172, down 6.09%, on 242,328 volume with 28 trades. The average volume for the last 60 days is 357,802 and the stock's 52-week low/high is $0.0405/$0.175.

Giggles N' Hugs, Inc. (GIGL)

SeriousTraders, Tip.us, Investor's Insight, RedChip, OTCJournal, StocksToBuyNow, SmallCap Network, SmallCapVoice, and Money and Markets reported earlier on Giggles N' Hugs, Inc. (GIGL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Giggles N' Hugs, Inc. is the owner and operator of family-friendly restaurants. These restaurants bring together high-end, organic food with active, leading-edge play and entertainment for children. The Company features high-quality menus made from fresh and local foods. Established in 2010, Giggles N' Hugs is based in Glendale, California.

Each Giggles N' Hugs location offers an upscale, family-friendly atmosphere with a dedicated play area for children 10 and younger. In addition, the Company features nightly entertainment. This includes magic shows, concerts, puppet shows, and face painting, as well as party packages for families.

Membership at Giggles N' Hugs comes with benefits. These include first access to its special kids’ events, monthly deals, and unlimited visits for the whole family.

The Company was listed best family & kid-friendly restaurants by CitySearch and GoCityKids. Giggles N’ Hugs has locations in Topanga and Glendale, California.

Giggles N’ Hugs was also voted the #1 birthday party place in Los Angeles by Nickelodeon. Moreover, it was voted "Best Pizza in Los Angeles" by Nickelodeon.

In May of 2017, Giggles N’ Hugs announced that it signed a non-binding Letter of Intent (LOI) with City Scape trading (franchisee), a Bahrain-based hospitality company, to open up to two Giggles N’ Hugs franchise locations in Bahrain with more locations to come if successful. With this master license agreement, Giggles N’ Hugs will receive up-front development fees for each location, and also an ongoing royalty based on a percentage of monthly gross sales.

Giggles N’ Hugs has engaged Pacific Shore Ventures to explore potential synergistic acquisition opportunities. PacificShore is a global specialty finance and Mergers & Acquisitions (M&A) firm.

Giggles N' Hugs is targeting companies that are cash flow positive and have minimum annual revenue of $5 million or more. PacificShore will work to identify and create target company profiles, introduce, initiate negotiations, and ultimately facilitate the closing of such potential companies and introduce traditional banking relationships for Giggles N' Hugs to finance the acquisitions.

Last month, Giggles N’ Hugs announced that it now accepts Bitcoin as a payment option for customers. Via BitPay, Giggles N’ Hugs customers can use their phones or email to complete payments. By way of BitPay, Giggles N Hugs receives direct bank deposits for a flat 1 percent settlement charge.

Giggles N' Hugs, Inc. (GIGL), closed Thursday's trading session at $0.0187, up 10.00%, on 279,449 volume with 14 trades. The average volume for the last 60 days is 343,079 and the stock's 52-week low/high is $0.016/$0.26.

Tofutti Brands, Inc. (TOFB)

Market Exclusive, Zacks, and MarketWatch reported on Tofutti Brands, Inc. (TOFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tofutti Brands, Inc. develops and distributes a complete line of dairy-free products. Its products are available across the United States and in more than 30 countries. Tofutti Brands’ products serve the needs of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, as well as those who want to have a healthier low-fat diet. Established in 1981, Tofutti Brands is headquartered in Cranford, New Jersey.

All Tofutti Brands products are certified Kosher Parve. This means that none of the Company’s products ever contain any dairy whatsoever. This means no milk by-products either, such as casein, whey, skim milk powder, or dairy lactic acid.

The Company sells greater than 50 milk-free foods. These include frozen desserts, cheese products, and prepared frozen dishes. Tofutti Brands’ product line includes dairy-free ice cream pints, Tofutti Cutie® sandwiches, and novelty bars.

Pertaining to wholesale and/or food service, Premium Tofutti frozen dessert is available in 3 gallon containers. Tofutti Better Than Cream Cheese, Tofutti Better Than Ricotta Cheese, Tofutti Better Than Mozzarella Cheese, and Tofutti Better Than Sour Cream are available in an assortment of bulk sizes. These include 30 lb. blocks, 5 lb. containers, and 1 oz. portion controlled cups (cream cheese only).

In addition, Tofutti Brands has an increasing array of prepared foods. These include Pizza Pizzaz® and Mintz's Blintzes® - all made with Tofutti's milk-free cheeses, including Better Than Cream Cheese® and Sour Supreme®. Tofutti dairy free cheeses, frozen desserts, as well as frozen foods can be found in major supermarkets and health food stores.

This past November, Tofutti Brands announced its results for the thirteen and thirty-nine week periods ended September 30, 2017. Net Income for the thirteen weeks ended September 30, 2017 grew to $323,000 or $0.06 per share (basic and diluted). This is in comparison to Net Income of $32,000, or $0.01 per share (basic and diluted), for the thirteen weeks ended October 1, 2016.

Net Income for the thirty-nine weeks ended September 30, 2017 was $420,000, or $0.08 per share (basic and diluted). This is in comparison to Net Income of $356,000, or $0.07 per share (basic and diluted), for the thirty-nine weeks ended October 1, 2016.

Mr. David Mintz, Tofutti Brands’ Chairman and Chief Executive Officer, stated in November, "I am pleased with the increase in sales of our vegan cheese products during the thirteen and the thirty-nine week periods ended September 30, 2017 and our improved profitability in 2017. We achieved these improved results despite the headwinds encountered in our frozen dessert product production and sales. Our continuing focus on reducing operating expenses and improving margins are evident in our improved gross profit margin in the thirteen weeks ended September 30, 2017…”

Tofutti Brands, Inc. (TOFB), closed Thursday's trading session at $2.16, up 5.37%, on 2,230 volume with 4 trades. The average volume for the last 60 days is 9,174 and the stock's 52-week low/high is $1.51/$3.04.

Electra Meccanica Vehicles Corp. (ECCTF)

Zacks, MarketWatch, OTC Markets, Streetwise Reports, Stockhouse, Barchart, and Business Insider reported on Electra Meccanica Vehicles Corp. (ECCTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Electra Meccanica Vehicles Corp. is a designer and manufacturer of electric vehicles. The Company is developing clean, sustainable and renewable transportation solutions, which help fight carbon pollution and climate change. Electra Meccanica has its subsidiary Intermeccanica. With it, it is delivering next generation affordable electric vehicles to the masses. Electra Meccanica Vehicles is headquartered in Vancouver, British Columbia. The Company’s shares trade on the OTCQB.

Electra Meccanica is being built in collaboration with world-renowned coach builder, Intermeccanica. For 57 years Intermeccanica has successfully been building high-end specialty cars. Intermeccanica’s award-winning and high-quality reproductions of Porsche Speedsters and Roadsters transformed the market.

Fundamentally, Electra Meccanica Vehicles combines Founder Jerry Kroll’s wide-ranging background in the race car industry with Henry Reisner’s
Intermeccanica Custom Coach Builders’ 50 years of experience in building high-quality, specialty vehicles.

Electra Meccanica builds the unique, all-electric SOLO. This is a single passenger vehicle. It underwent development to revolutionize the manner in which people commute. Electra Meccanica also builds the Tofino convertible. This is an elegant high-performance sports car.

The intelligent layout and use of advanced materials enable the SOLO to attain strength and durability. This is while maintaining weight of just over 450kgs/1,000lbs. The basis for the SOLO and future line of vehicles is the aerospace composite chassis platform. Patents are filed for the Modular Rolling Chassis, the overall SOLO shape, as well as other innovations.

The SOLO drivetrain is a high performance electric rear drive motor (up to 82 hp and 128 Nm torque).The battery system/range is 16.1 kW/h Lithium-Ion - up to a 160 km range. The storage capacity is 245 Liters/40 liters – rear/front storage.

The SOLO charging system/time is Dual 220/110 V – 3/6 hours charging time. The performance is 130 km/h top speed 0-100 km/h in 8.0 seconds.

Last month, Electra Meccanica announced that it was awarded the Automotive Innovation Award by IHS Markit at ShowStoppers® at Consumer Electronics Show (CES) 2018, for its new SOLO electric vehicle. IHS Markit is an international leader in critical information, analytics and expertise. The Innovation Awards at ShowStoppers® took place in January in Las Vegas, Nevada.

Electra Meccanica Vehicles Corp. (ECCTF), closed Thursday's trading session at $4.65, even for the day, on 307 volume with 2 trades. The average volume for the last 60 days is 1,926 and the stock's 52-week low/high is $1.50/$8.00.

RedHawk Holdings Corp. (IDNG)

Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, and Hot Stock Profits reported previously on RedHawk Holdings Corp. (IDNG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company headquartered in Lafayette, Louisiana. The Company, by way of its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services.

RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings lists on the OTCQB.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is an innovative, closed cabinet, nominal dose transmission full body x-ray scanner.

Via its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers unique product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s commitment is to healthcare and the NHS. Its dedication is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from different commercial properties under long-term lease. In addition, its real estate investment unit holds limited liability company interest in varied commercial restoration projects in Hawaii.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

Recently, RedHawk Holdings announced its results for the three-month period ended September 30, 2017, as the Company continues to methodically build and develop its branded generic pharmaceutical and medical device business.

For the three-month period ended September 30, 2017, RedHawk Holdings reported a smaller than expected consolidated net loss attributable to RedHawk of $55,464 on gross revenues of $67,893 versus a consolidated net loss attributable to RedHawk of $193,561 on gross revenues of $499,280 for the comparable three-month period ended September 30, 2016.

RedHawk Holdings Corp. (IDNG), closed Thursday's trading session at $0.0079, up 1.28%, on 15,000 volume with 1 trade. The average volume for the last 60 days is 471,267 and the stock's 52-week low/high is $0.0032/$0.021.

TechCare Corp. (TECR)

InvestorsHub, OTC Markets, Investing, Barchart, Stockhouse, 4-Traders, GuruFocus, PennyStockTweets, Investors Hangout, and Emerging Growth reported on TechCare Corp. (TECR), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, TechCare Corp. has an innovative delivery platform that uses vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform utilizing vaporization of different natural, plant-based compounds, to enable a wide assortment of treatment solutions. A technology enterprise, TechCare is based in New York, New York.

TechCare has a strategic partnership agreement with HoMedics, one of the world's leading brands in health and wellness products. HoMedics will manufacture, market, and distribute TechCare's Novokid products in the United States, Canada, Brazil, Argentina, Colombia, and Costa Rica. The products will be co-branded as HoMedics products powered by TechCare.

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap.

Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, and eggs. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid uses a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device.

Novokid uses a simple 10 minute dry treatment. The treatment requires no rinsing or washing. The treatment is fast, dry, and clean.

Furthermore, it is easily administered at home or while mobile. In addition, Novokid can be used as a maintenance and preventative treatment if used regularly.

Last month, TechCare announced that it signed its first distribution agreement with MWMedical B.V. for TechCare's Novokid lice treatment device, which addresses a $1.8 billion international market, and a European market estimated to exceed $500 million. MWMedical is a foremost distributor of medical devices in the Netherlands.

This multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments. The distributor has placed its first order of Novokid's products, 2,500 kits. They will be available in the Netherlands this month. The Netherlands represents the first success for TechCare among 28 European countries that the Company can sell to following the receipt of CE Approval.

Zvi Yemini, TechCare’s Chairman, said, "TechCare is delighted to announce its first agreement for Novokid with MWMedical to provide TechCare's leading technology with the broad representation of this organization in Netherlands. We are proud that after a wide-ranging evaluation, MWMedical has selected TechCare's technology. Beginning in February, the Dutch market will now have wide access to the superior Novokid lice treatment device."

TechCare Corp. (TECR), closed Thursday's trading session at $0.40, up 2.56%, on 1,233 volume with 2 trades. The average volume for the last 60 days is 4,444 and the stock's 52-week low/high is $0.02/$1.50.

Maricann Group, Inc. (MRRCF)

Stockhouse, The Street, MarketWatch, 4-Traders, NewCannabisVentures, Marketwired, Investors Hub, Investopedia, OTC Markets, Barchart, Weed Newswire, Insider Financial, YCharts, and TradingView reported on Maricann Group, Inc. (MRRCF), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Maricann Group, Inc. produces and distributes marijuana for medical purposes. It offers dried marijuana, cannabis oil, and gums. In addition, the Company provides accessories. This includes vaporizers, grinders, as well as other paraphernalia. Maricann Group has its head office in Langton, Ontario.

Maricann Group is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company secured a cultivation license in March 2014. It started selling dried cannabis in January 2015 and extracts in October 2016. Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and also distribute cannabis.

Maricann’s Germany-based Ebersbach facility targets the huge European market with 820,000 sq. ft. of cultivation space and more than 12,000 patients. Maricann Group has developed educational programming for patients and healthcare professionals. Via exclusive pharmacy agreements with approximately 20 percent of the nation’s pharmacies, Maricann is working to become a foremost provider of cannabis at physical point-of-sale locations that patients trust.

The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. Phase One is to be completed in Q2 2018. This will give Maricann capacity to grow 22,500 kg.

Phase 2 construction will start in the second half of 2018. It will provide an additional 635,000 square feet of grow space. Phase 3 is also scheduled to start in the second half of this year. It will bring the Company’s total growing and processing space to 942,000 square feet.

Maricann Group acquired NanoLeaf Technologies in August 2017. NanoLeaf is a biotechnology company possessing licensing rights to several internationally patented technologies, which provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

In November 2017, Maricann Group announced that it entered into a non-binding Letter of Intent (LOI) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing British Columbia's private liquor industry that outlines a proposed relationship between ABLE BC and Maricann Group for, among other things, the supply of Maricann product to ABLE BC members.

With this LOI, ABLE BC will agree to provide Maricann with distribution channels for its recreational stable of products. This includes JuJu Royal's curated quality strains. This will ensure ABLE's over 1,000 members comprising private liquor stores, neighborhood pubs, bars/nightclubs and hotel liquor licensees have access to Maricann's stable of established premium cannabis products.

Maricann Group, Inc. (MRRCF), closed Thursday's trading session at $2.5427, down 5.65%, on 30,045 volume with 106 trades. The average volume for the last 60 days is 160,782 and the stock's 52-week low/high is $0.8698/$3.60.

DynaResource, Inc. (DYNR)

Vantage Wire and WSIC News reported earlier on DynaResource, Inc. (DYNR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

DynaResource, Inc. is a Junior Resource Company with its corporate office in Irving, Texas. The Company holds 80 percent of the outstanding shares of DynaResource de Mexico, S.A. de C.V., (DynaMexico). DynaMexico owns 100 percent of the mineral concessions and related interest to the San Jose de Gracia District (SJG). This encompasses roughly 69,133 hectares in Northern Sinaloa, Mexico. DynaResource lists on the OTC Markets Group’s OTCQB.

DynaUSA currently holds 80 percent of the total outstanding Capital of DynaMexico. DynaUSA currently holds 100 percent of DynaMineras.

The SJG is 15 square kilometers mineralized area. It has historic production of 1 M Oz. Gold, bonanza grades. The Metallurgy Program is completed. It confirmed 95 percent recoveries in metallurgical testing and in pilot production operation.

At present, the SJG Property contains the potential for hosting a greater than 3,000,000 Oz. AU resource. DynaMexico operated a small-scale production at the SJG Property from mid 2003 to June 2006. It reported Production of 18,500 Oz., at an average grade of 20 g/t. AU, with average production costs of $175/Oz.

DynaResource focused its efforts in mid 2006 on the financing, exploration, and development of SJG. At September 1, 2006, it signed a definitive agreement with Goldgroup Mining, Inc., to provide for an $18 million financing of exploration and development activities at the SJG. At March 15, 2011, Goldgroup had contributed the $18M.

DynaResource announced in 2017 that Mr. Eduardo Luna was appointed to the Company's Board of Directors, effective March 1, 2017. DynaUSA announced that its wholly-owned subsidiary, Mineras de DynaResource S.A. de C.V. (DynaMineras), the exclusive operator of the San Jose de Gràcia Project (SJG) in the State of Sinaloa, México, appointed Mr. Luna as Special Advisor to the President of DynaMineras.

Mr. Luna's experience includes serving as a Member of the Board of Directors for major mining companies, which have achieved success at the highest level of the mining industry. Currently, Mr. Luna serves as a member of the Board of Directors of Silver Wheaton Corp. Moreover, he has served as a Member of the Board of Directors of Goldcorp, Inc., Primero Mining Corp., and Alamos Gold, Inc.

For the SJG Project, a Surface Rights Agreement is completed. There is confirmation of significant vein deposits; with bonanza grades. There is also location of bulk tonnage potential at Palos Chinos; (15 meters @ 3 grams/ton; 7m @ 7 grams/ton).

Also, there is a 200 Ton/Day Flotation Mill in place. It was operational at April, 2003. However, it is currently suspended to concentrate on exploration/drilling.

DynaResource, Inc. (DYNR), closed Thursday's trading session at $1.20, even for the day, on 55,537 volume with 8 trades. The average volume for the last 60 days is 2,195 and the stock's 52-week low/high is $0.65/$1.63.


The QualityStocks
Company Corner


Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.1352, up 13.61%, on 442,990 volume with 85 trades. The stock’s average daily volume over the past 60 days is 974,980, and its 52-week low/high is $0.0045/$0.52.

Epazz, Inc. (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that the company’s patent-pending Blockchain Smart Legal Contracts Technology will be called Cordtell (www.cordtell.com). Cordtell reduces fraud in business transactional contracts.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz's Patent Pending Blockchain Smart Legal Contracts Technology Will be Called Cordtell and Plans to Release the Blockchain Storage Technology During the Third Quarter of 2018

Epazz ZenaPay Releases New Version of Blockchain Wallet That Supports Multiple Cryptocurrencies With Ethereum and Bitcoin; ZenaPay Wallet Has Been Downloaded Over 23,000 Times

MoneyTV with Donald Baillargeon, 2/9

AnalytixInsight Inc. (TSX.V:ALY) (OTCQB:ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF). Today, AnalytixInsight Inc. closed trading at $0.3981, up 12.43%, on 75,750 volume with 6 trades. The stock’s average daily volume over the past 60 days is 39,684 and its 52-week low/high is $0.15/$0.6898.

As artificial intelligence breakthroughs make the science of predicting the future more reality than fiction, companies like AnalytixInsight, Inc. (TSX.V: ALY) (OTCQB: ATIXF) are bending that science to the wills of millions of market investors who hope for a heads up on corporate activities such as dividend cuts, as well as the stock swings that may accompany news of earnings reports, consumer trends and political machinations.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company's flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube's online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube's freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy's largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo's 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo's established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners. Disclaimer

AnalytixInsight Inc. Blog

AnalytixInsight Inc. News:

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Uses AI to Enable Critical Decisions

NetworkNewsAudio Announces Audio Press Release (APR) on Promising AI Solutions in Financial Technology

NetworkNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Assesses Opportunities in the Shifting Data Landscape

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.705, up 0.29%, on 559,139 volume with 688 trades. The stock’s average daily volume over the past 60 days is 496,367 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently announced its entry into a licensing agreement with Cannfections Group Inc. To view the full article released today on this news item, visit: http://cnw.fm/oUs26. Also today, CannabisNewsWire put out a report on how LXRP is generating revenue and knowledge through both licensing of its IP portfolio and advancement of R&D projects.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Utilizes Oral Digestion Technology to Expand Product Line

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP): IP Portfolio, Licensing and R&D are Keys to Growth in 2018

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Best-in-Class Product Line

AV1 Group, Inc. (AVOP)

The QualityStocks Daily Newsletter would like to spotlight AV1 Group, Inc. (AVOP). Today, AV1 Group, Inc. closed trading at $0.0252, off by 15.44%, on 77,106 volume with 5 trades. The stock’s average daily volume over the past 60 days is 67,720 and its 52-week low/high is $0.017/$0.28.

Investment and holding company AV1 Group (OTC: AVOP) recently announced the addition of Jon Fortune to its team as a strategic corporate advisor to help drive its LED Division. To view the full article released today by NetworkNewsWire on this subject, visit: http://nnw.fm/v2vOq

AV1 Group, Inc. (AVOP), is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint in high-growth markets, the business model followed calls for incubating and supporting the best opportunities.

The company seeks to discover inspired entrepreneurs with innovative ideas that are poised for significant revenue generation. Management expertise can be seen in the development of embryonic-stage subsidiaries as the company brings a spectrum of backgrounds to the table with a significant resource of knowledge and experience to every venture. AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets.

AV1 Group companies include:

  • XFIRESmartSystems.com – Intelligent lighting solutions and wireless access for many different applications.
  • VaporHighUSA.com – Over 800 vaping products; bitcoin payments accepted.
  • DentalCannatizer.com – Revolutionary dual jet dental water jet integrates hemp oil infusing.
  • IntelligentLightingCorp.com – Comprehensive, energy-efficient lighting solutions.
  • CannaLighting.com – Wholly owned subsidiary building strategic relationships in the LED sector to provide solutions for grow houses and cultivation centers.
  • MJIQ – First, comprehensive, enterprise-grade integrated software suite being developed for the legal cannabis industry.
  • Hemptory.com – Engaging online destination for all hemp and cannabis related products and services.
  • Lawster.com – Puts consumers and small businesses in contact with legal services and service providers.
  • MJTestLabs.com – Under development website will serve cannabis dispensaries, laboratories and industry affiliates.

AV1 Group's business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella. Disclaimer

AV1 Group, Inc. Blog

AV1 Group, Inc. News:

NetworkNewsBreaks – AV1 Group, Inc. (AVOP) Adds Strategic Corporate Advisor to Drive LED Division

AV1 Group, Inc. (AVOP) Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

AV1 Group Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.0223, off by 10.80%, on 3,438 volume with 3 trades. The stock’s average daily volume over the past 60 days is 226,956 and its 52-week low/high is $0.02/$0.33.

Skinvisible (OTCQB: SKVI), a developer of innovative drug delivery technology, through its Kintari subsidiary, produces the hand sanitizer, DermSafe®. To view the full article released today by NetworkNewsWire on this subject, visit: http://nnw.fm/w4FsM

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) DermSafe Hand Sanitizer Stops Influenza A from Spreading

Skinvisible, Inc. (SKVI) Products Can Offer Protection against Highly Contagious Viruses like H3N2

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.40, off by 8.05%, on 189,303 volume with 63 trades. The stock’s average daily volume over the past 60 days is 310,355 and its 52-week low/high is $0.0711/$0.72.

Tapinator, Inc. (OTCQB: TAPM), a leading developer and publisher of mobile games and decentralized apps (DApps) on the iOS, Google Play, Amazon, and Ethereum platforms, today announces that it will soon be releasing BitPainting, a crypto-collectibles application for the global art market. A beta release of the platform is scheduled for this coming April, and interested collectors may sign up for Beta Access at BitPainting.com. Also today, MarketNewsUpdates released a report featuring TAPM which takes a look at how innovative technology companies continue to identify new uses for blockchain and deploy the technology in various industries.

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Tapinator Announces BitPainting

Why a Rising Number of Industries Are Embracing Blockchain Technology Well Beyond Crypocurrencies

NetworkNewsBreaks – Tapinator, Inc. (TAPM) Well-positioned in Emerging Decentralized Apps Market

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.607, off by 1.30%, on 10,383,309 volume with 2,869 trades. The stock’s average daily volume over the past 60 days is 13,574,359, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding, Inc. (POTN) announced today that its subsidiary, Diamond CBD, Inc., has successfully launched a new product line, Meds BioTech, which expands the Company’s product marketing and distribution into health-focused distribution channels, such as vitamin shops, health product stores, gyms, chiropractic offices and physicians offices, which the Company regards as a new industry sector for the distribution of its products.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding Successfully Launches Meds BioTech Line into New Industry Sector

Marijuana Stocks Gaining Ground After Latest Press

PotNetwork Holding, Inc. Reports Record Breaking January Revenues of $2.1 Million

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.025, off by 10.10%, on 16,790,127 volume with 538 trades. The stock’s average daily volume over the past 60 days is 16,124,061, and its 52-week low/high is $0.0141/$0.16.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. has finalized a JV Agreement with Equity and Exclusivity in Sales and Marketing with GreenBox POS, LLC.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

The Missing Piece: MoneyTrac Technology Aims to Disrupt Payment Technologies in JV with GreenBox POS, a Blockchain Company

Global Payout, Inc. Supply Chain Finance Subsidiary SecurCapital Corp Receives Initial Customer Letter of Intent (LOI)

MoneyTrac Technology and Crypto Cowboys Introduce Open Network at Crypto Conference in Texas

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG). Today, Medical Cannabis Payment Solutions closed trading at $0.0445, off by 1.11%, on 590,074 volume. The stock’s average daily volume over the past 60 days is 769,168, and its 52-week low/high is $0.0161/$0.155.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an article featuring Medical Cannabis Payment Solutions (OTC:REFG), a client of NNW committed to providing end-to-end management for medicinal marijuana operations. To view the full publication, visit: http://nnw.fm/dyO7p

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company's state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company's unique "StateSourced" proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven't been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin's cryptocurrency ($Weed) with Medical Cannabis Payment Solutions' StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

"We've completed our transition from development stage to revenue stage," says Roberts. "We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases."

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry. Disclaimer

Medical Cannabis Payment Solutions Company Blog

Medical Cannabis Payment Solutions News:

NetworkNewsWire Announces Publication on the Commitment of Medical Cannabis Payment Solutions (REFG) to Regulatory Compliance Ahead of Utah Bill

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Helps Cannabis Distributors Remain Compliant with Green Platform

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Solving the Banking Nightmare of the Medical Marijuana Industry


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Broad Street
(GLOH) +60.00%


(MBRX) +53.85%


(AMRH) +30.67%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251